Skip to content
Back to VCEL

Vericel Corp

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
47
Purchases
0
Sales
47
Purchase value
$0.00
Sale value
$12.89M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Jonathan SiegalPrincipal Accounting Officer
4
Filed Nov 17, 2026Period of report Nov 13, 20260001140361-26-044491
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 13, 2026
Common StockF1263$57.78$15.20K1,259Direct
SaleNov 13, 2026
Common StockF1935$57.62$53.87K1,259Direct
SaleNov 13, 2026
Common StockF1687$57.80$39.71K1,259Direct
Filing footnotes · 3
  1. F1These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  2. F2These options, representing the right to purchase 4,198 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted
  3. F3These options, representing the right to purchase 9,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.
Open on SEC EDGAR
Joseph Anthony Mara JrChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Nov 12, 2026Period of report Nov 9, 20260001140361-26-043494
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 11, 2026
Common StockF2F18$59.75$478.0016,186Direct
SaleNov 9, 2026
Common StockF2F125,000$58.26$1.46M16,186Direct
Filing footnotes · 3
  1. F1These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  2. F2The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  3. F3These options, representing the right to purchase 160,000 shares, became exercisable on January 25, 2022, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
Open on SEC EDGAR
Kevin F McLaughlinDirector
4Rule 10b5-1 plan disclosed
Filed Nov 12, 2026Period of report Nov 10, 20260001140361-26-043491
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 10, 2026
Common StockF17,000$58.96$412.72K18,300Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.
  2. F2These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 2, 2018, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
Open on SEC EDGAR
Robert L MD ZerbeDirector
4Rule 10b5-1 plan disclosed
Filed Nov 12, 2026Period of report Nov 9, 20260001140361-26-043488
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 9, 2026
Common StockF12,000$57.88$115.76K32,995Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026.
  2. F2These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 2, 2018, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
Open on SEC EDGAR
Joseph Anthony Mara JrChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Nov 9, 2026Period of report Nov 5, 20260001140361-26-042785
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 6, 2026
Common StockF2F114,068$53.41$751.37K16,186Direct
SaleNov 6, 2026
Common StockF2F114,573$53.43$778.64K16,186Direct
SaleNov 5, 2026
Common StockF2F110,932$53.40$583.77K16,186Direct
SaleNov 5, 2026
Common StockF2F110,427$53.73$560.24K16,186Direct
Filing footnotes · 4
  1. F1These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  2. F2The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  3. F3These options, representing the right to purchase 64,269 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted.
  4. F4These options, representing the right to purchase 46,250 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.
Open on SEC EDGAR
Sean C. FlynnChief Legal Officer
4Rule 10b5-1 plan disclosed
Filed Nov 6, 2026Period of report Nov 5, 20260001140361-26-042464
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 5, 2026
Common StockF2F115,000$51.92$778.80K1,990Direct
Filing footnotes · 3
  1. F1These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  2. F2The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  3. F3These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
Open on SEC EDGAR
Jonathan SiegalPrincipal Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Nov 6, 2026Period of report Nov 5, 20260001140361-26-042463
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 5, 2026
Common StockF2F11,500$52.90$79.35K1,259Direct
Filing footnotes · 3
  1. F1These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  2. F2The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.
  3. F3These options, representing the right to purchase 4,198 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted
Open on SEC EDGAR
Robert L MD ZerbeDirector
4Rule 10b5-1 plan disclosed
Filed Nov 6, 2026Period of report Nov 4, 20260001140361-26-042462
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 5, 2026
Common StockF1500$55.00$27.50K32,995Direct
SaleNov 5, 2026
Common StockF12,500$51.67$129.18K32,995Direct
SaleNov 4, 2026
Common StockF12,500$45.40$113.50K32,995Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026.
  2. F2These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 2, 2018, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
Open on SEC EDGAR
Kevin F McLaughlinDirector
4Rule 10b5-1 plan disclosed
Filed Aug 14, 2026Period of report Aug 12, 20260001140361-26-033143
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 12, 2026
Common StockF17,000$44.53$311.71K18,300Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.
  2. F2These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 2, 2018, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
Open on SEC EDGAR
Michael HalpinChief Operating Officer
4Rule 10b5-1 plan disclosed
Filed Aug 5, 2026Period of report Aug 3, 20260001140361-26-031417
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 3, 2026
Common StockF2F110,000$46.84$468.40K16,394Direct
Filing footnotes · 3
  1. F1These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  2. F2The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  3. F3These options, representing the right to purchase 76,250 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 6, 2019, which was one quarter after the date on which the option was granted.
Open on SEC EDGAR
Jonathan SiegalPrincipal Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Jul 31, 2026Period of report Jul 30, 20260001140361-26-030487
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 30, 2026
Common StockF2F11,500$48.90$73.35K1,078Direct
SaleJul 30, 2026
Common StockF2F12,500$48.90$122.25K1,078Direct
SaleJul 30, 2026
Common StockF2F1500$48.90$24.45K1,078Direct
Filing footnotes · 4
  1. F1These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  2. F2The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.
  3. F3These options, representing the right to purchase 4,198 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted
  4. F4These options, representing the right to purchase 9,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.
Open on SEC EDGAR
Jonathan SiegalPrincipal Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Jun 30, 2026Period of report Jun 26, 20260001140361-26-026932
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 26, 2026
Common StockF1F2232$44.90$10.42K886Direct
SaleJun 26, 2026
Common StockF1F22,500$44.90$112.25K886Direct
Filing footnotes · 3
  1. F1The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.
  2. F2These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  3. F3These options, representing the right to purchase 9,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.
Open on SEC EDGAR
Joseph Anthony Mara JrChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jun 30, 2026Period of report Jun 26, 20260001140361-26-026931
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 26, 2026
Common StockF1F25,000$44.75$223.75K16,009Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  2. F2These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open on SEC EDGAR
Jonathan Mark HopperChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Jun 30, 2026Period of report Jun 26, 20260001140361-26-026930
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 26, 2026
Common StockF2F15,000$45.00$225.00K75,753Direct
SaleJun 26, 2026
Common StockF2F15,000$45.00$225.00K75,753Direct
Filing footnotes · 3
  1. F1These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  2. F2The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025.
  3. F3These options, representing the right to purchase 30,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.
Open on SEC EDGAR
Sean C. FlynnChief Legal Officer
4Rule 10b5-1 plan disclosed
Filed Jun 30, 2026Period of report Jun 26, 20260001140361-26-026929
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 26, 2026
Common StockF2F115,000$45.64$684.60K1,647Direct
Filing footnotes · 3
  1. F1These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  2. F2The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  3. F3These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
Open on SEC EDGAR
Michael HalpinChief Operating Officer
4Rule 10b5-1 plan disclosed
Filed Jun 22, 2026Period of report Jun 18, 20260001140361-26-025952
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 18, 2026
Common StockF2F110,000$40.24$402.40K16,248Direct
Filing footnotes · 3
  1. F1These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  2. F2The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  3. F3These options, representing the right to purchase 76,250 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 6, 2019, which was one quarter after the date on which the option was granted.
Open on SEC EDGAR
Sean C. FlynnChief Legal Officer
4Rule 10b5-1 plan disclosed
Filed Jun 22, 2026Period of report Jun 18, 20260001140361-26-025951
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 18, 2026
Common StockF2F115,000$40.21$603.15K1,647Direct
Filing footnotes · 3
  1. F1These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  2. F2The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  3. F3These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
Open on SEC EDGAR
Jonathan Mark HopperChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Jun 4, 2026Period of report Jun 2, 20260001140361-26-023988
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 2, 2026
Common StockF2F14,375$35.00$153.13K75,753Direct
Filing footnotes · 3
  1. F1These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  2. F2The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025.
  3. F3These options, representing the right to purchase 26,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 6, 2019, which was one quarter after the date on which the option was granted.
Open on SEC EDGAR
Kevin F McLaughlinDirector
4Rule 10b5-1 plan disclosed
Filed May 15, 2026Period of report May 13, 20260001140361-26-021656
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 13, 2026
Common StockF13,500$32.83$114.91K18,300Direct
SaleMay 13, 2026
Common StockF13,500$32.82$114.87K18,300Direct
Filing footnotes · 3
  1. F1The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.
  2. F2These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 3, 2017, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
  3. F3These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 2, 2018, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
Open on SEC EDGAR
Paul K WottonDirector
4
Filed May 13, 2026Period of report May 11, 20260001140361-26-021040
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 11, 2026
Common Stock2,500$33.05$82.63K26,302Direct
SaleMay 11, 2026
Common Stock7,500$32.64$244.80K18,802Direct
Open on SEC EDGAR
Joseph Anthony Mara JrChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed May 8, 2026Period of report May 7, 20260001140361-26-020031
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 7, 2026
Common StockF1F25,000$40.50$202.50K21,009Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  2. F2These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open on SEC EDGAR
Jonathan SiegalPrincipal Accounting Officer
4Rule 10b5-1 plan disclosed
Filed May 8, 2026Period of report May 6, 20260001140361-26-020030
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 7, 2026
Common StockF1F21,422$40.50$57.59K1,118Direct
SaleMay 6, 2026
Common StockF1F23,433$38.00$130.45K2,540Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.
  2. F2These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open on SEC EDGAR
Jonathan Mark HopperChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Apr 6, 2026Period of report Apr 2, 20260001140361-26-013334
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 2, 2026
Common StockF2F13,472$35.00$121.52K75,556Direct
Filing footnotes · 3
  1. F1These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  2. F2The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025.
  3. F3These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
Open on SEC EDGAR
Heidi HagenDirector
4Rule 10b5-1 plan disclosed
Filed Mar 25, 2026Period of report Mar 23, 20260001140361-26-011091
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 23, 2026
Common StockF115,000$32.41$486.15K31,850Direct
Filing footnotes · 3
  1. F1The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.
  2. F2These options, representing the right to purchase 15,000 shares, were originally granted on May 4, 2016, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
  3. F3These options, which were awarded on May 4, 2016, would otherwise expire and become forfeitable on May 4, 2026.
Open on SEC EDGAR
Sean C. FlynnChief Legal Officer
4Rule 10b5-1 plan disclosed
Filed Mar 4, 2026Period of report Mar 2, 20260001140361-26-007855
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 2, 2026
Common StockF1F26,421$34.75$223.13K1,262Direct
SaleMar 2, 2026
Common StockF1F215,000$35.36$530.40K1,262Direct
Filing footnotes · 3
  1. F1The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  2. F2These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  3. F3These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
Open on SEC EDGAR
Michael HalpinChief Operating Officer
4Rule 10b5-1 plan disclosed
Filed Mar 4, 2026Period of report Mar 2, 20260001140361-26-007853
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 2, 2026
Common StockF1F210,305$35.30$363.77K16,080Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  2. F2These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open on SEC EDGAR
Kevin F McLaughlinDirector
4Rule 10b5-1 plan disclosed
Filed Feb 13, 2026Period of report Feb 11, 20260001140361-26-005417
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 11, 2026
Common StockF17,000$34.66$242.62K15,100Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024.
  2. F2These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 3, 2017, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
Open on SEC EDGAR
Michael HalpinChief Operating Officer
4Rule 10b5-1 plan disclosed
Filed Jan 9, 2026Period of report Jan 7, 20260001140361-26-000834
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 7, 2026
Common StockF2F110,000$40.48$404.80K16,080Direct
Filing footnotes · 3
  1. F1These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  2. F2The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2024.
  3. F3These options, representing the right to purchase 76,250 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 6, 2019, which was one quarter after the date on which the option was granted.
Open on SEC EDGAR
Paul K WottonDirector
4
Filed Dec 4, 2025Period of report Dec 2, 20250001140361-25-044347
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 3, 2025
Common Stock2,500$37.83$94.58K25,602Direct
SaleDec 2, 2025
Common Stock2,500$37.97$94.93K28,102Direct
Open on SEC EDGAR
Jonathan Mark HopperChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Dec 4, 2025Period of report Dec 2, 20250001140361-25-044348
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 2, 2025
Common StockF2F11,652$39.14$64.66K66,562Direct
Filing footnotes · 3
  1. F1These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  2. F2The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025.
  3. F3These options, representing the right to purchase 48,750 shares, became exercisable in quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 11, 2020.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.